2018
DOI: 10.1016/j.jddst.2018.01.014
|View full text |Cite
|
Sign up to set email alerts
|

Composite smart mesoporous silica nanoparticles as promising therapeutic and diagnostic candidates: Recent trends and applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
28
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 52 publications
(28 citation statements)
references
References 184 publications
0
28
0
Order By: Relevance
“…An interesting concept of late in anticancer interventions are theranostic systems (i.e., combining diagnostic and therapeutic elements in a single platform) in which chemically modified phytochemicals could play a significant role [ 6 , 7 ]. Theranostic agents are highly advanced systems that can function to monitor the accumulation of various compounds (including nanomedicines) at target sites, quantify triggered drug release, and detect malignant cells in order to deliver a chemotherapeutic agent to the targeted site [ 7 , 8 ]. The ability to simultaneously detect and treat cancer also reduces patient mortality as a result of early disease detection and immediate treatment [ 9 ].…”
Section: Introductionmentioning
confidence: 99%
“…An interesting concept of late in anticancer interventions are theranostic systems (i.e., combining diagnostic and therapeutic elements in a single platform) in which chemically modified phytochemicals could play a significant role [ 6 , 7 ]. Theranostic agents are highly advanced systems that can function to monitor the accumulation of various compounds (including nanomedicines) at target sites, quantify triggered drug release, and detect malignant cells in order to deliver a chemotherapeutic agent to the targeted site [ 7 , 8 ]. The ability to simultaneously detect and treat cancer also reduces patient mortality as a result of early disease detection and immediate treatment [ 9 ].…”
Section: Introductionmentioning
confidence: 99%
“…Numerous reports have confirmed that, depending on the synthesis approach, silica nanoparticles have low cytotoxicity. Thus, the aim is to use the final product in medical trials and actually apply MSN in tumor-targeted delivery systems [113,114]. Reprinted from an open access source [16].…”
Section: Biomedical Applicationsmentioning
confidence: 99%
“…Furthermore, apart from having targeting properties, the surface decoration exhibits reduced undesirable interaction with the internal organelles. 167 Moreover, Lu et al concluded 50nm particle size is the optimal size for the drug delivery by MSNs with respect to 30nm or even 200nm. 168 Whereas, He et al demonstrated that as the size of MSNs increases, the excretion from urine also increases correspondingly.…”
Section: Toxicity Biocompatibility and Biodegradation Of Msnsmentioning
confidence: 99%